Rosetta Genomics Ltd.
CIK 0001362959
Revenue (TTM)
—
Q2 Jun 2017
Net Income (TTM)
$16.23M
−6.4% YoY
Q2 Jun 2017
EPS Diluted (TTM)
—
Q2 Jun 2017
Gross Margin
—
Q2 Jun 2017
Operating Margin
—
Q2 Jun 2017
Net Margin
—
Q2 Jun 2017
Free Cash Flow (TTM)
−$10.59M
Q2 Jun 2017
Cash
$1.33M
Q2 Jun 2017
Total Debt
—
Q2 Jun 2017
Shares Outstanding
1.84M sh
Q2 Jun 2017
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.